Stratview Research publishes a new report titled HPV Vaccines Market which is segmented by Type (Bivalent, Polyvalent), by Indication (Cervical Cancer, Anal Cancer, Penile Cancer, Oropharyngeal Cancer, Genital Warts, Others), by Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, Others) and Region (North America, Europe, Asia-Pacific, and Rest of the World).

Market Insights

The HPV vaccines market was estimated at USD 5.6 billion in 2021 and is likely to grow at a CAGR of 16.1% during 2022-2028 to reach USD 15.94 billion in 2028.

What is human papillomavirus (HPV)?

Human papillomavirus (HPV) infection is one of the most common sexually transmitted infections which is caused by HPV-related cancers, such as genital and cervical cancers. HPV infection vaccines are primarily used to prevent genital warts, cervical cancer, anal cancer, and vaginal cancer. Three commercially available HPV prevention vaccines, such as Gardasil 9 and Gardasil by Merck and Cervarix developed by GSK Plc, are known to be highly effective in preventing HPV infection and genital precancerous lesions.

COVID-19 IMPACT

The outbreak of the COVID-19 virus had a devastating impact on the HPV vaccine industry. The healthcare industry is currently facing major challenges as it is unable to provide proper medical facilities to cater to the ever-growing coronavirus patient pool. With the stringent imposition of lockdown and social distance regulations, there were limited check-ups of women suffering from sexually transmitted diseases. During the pandemic period in 2020, around 342,000 women lost their lives due to cervical cancer. Thus, a poor healthcare system due to limited medical professionals and funding affected the market growth.

Market Dynamics

The rising prevalence of cervical cancer among women is a prime factor augmenting the demand for HPV vaccines.

• Moreover, the growing need to reduce HPV infections further adds emphasis to the market growth in the near future.
• Furthermore, the government bodies in numerous countries are focusing on imposing stringent policies for supplying vaccines to prevent the burden of this disease thus boosting the product demand.
• However, these vaccines are short in supply and are available in limited amounts thus failing to cater to the rising need, thus affecting the market expansion.

Global HPV Vaccines Market Report Segments:

By type, the HPV vaccines market has been bifurcated into bivalent, polyvalent.

• Under these, the polyvalent segment accounted for the highest market share in 2021 and is projected to grow at a moderate CAGR in the coming years.
• This is mainly attributed to their low cost and performance efficiency and that they are highly popular, especially in the developing countries of Asia Pacific, thus bolstering the segment growth.

By region, the North American market witnessed the highest market share in 2021 and is estimated to register at a considerable CAGR during the review period. This is mainly attributed to the strong presence of well-established healthcare facilities, along with the ease in the availability of necessary resources. Moreover, people are aware of the presence of vaccines and related therapeutic procedures, thus augmenting the for vaccination and treatment, further boosting regional growth.

Why is this report beneficial?

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

It also offers –

-        Market Overview

-        Key Manufacturers Profiles

-        Market Analysis by Region

-        Market Segment by Type

-        Market Segment by Application

-        Raw Material and Supply Chain

-        Other Key Research Findings

All the data compiled by the market experts is the outcome of rigorous primary and secondary research conducted on the market players and reliable sources, including company white papers, journals, press releases, and more.

Key players active in the market –

The following are some of the key players in the HPV Vaccines Market:

• Lumetrics (The US),
• Marco (The US),
• Voptica (Spain),
• AMICO GROUP (UAE),
• NIDEK (Japan),
• Hanson Instruments (UK),
• Alcon (Switzerland), Carl Zeiss (Germany),
• Essilor (France), and Johnson & Johnson Visioncare Inc. (US).

Customization of the report –

At Stratview Research, the market researchers make a note of opportunities, drawbacks/bottlenecks, estimates, and information related to the market using experienced skills and verified methodologies. Our research reports offer an exceptional experience of innovative solutions and outcomes to the users. If required, user can also opt for customization of the report.

Connect with our team at –

Stratview Research

E-mail: sales@stratviewresearvch.com

Direct: +1-313-307-4176